Skip to main content

CMS Enhancing Oncology Model Updates: RFA Issued for Second Cohort

chemotherapy treatment with patient and doctor

Key CMMI updates to the EOM 

The Center for Medicare and Medicaid Innovation (CMMI) released exciting updates to the Enhancing Oncology Model (EOM) along with a new opportunity for a second cohort of participants.  

The EOM aims to enhance the quality of care for cancer patients while reducing costs under the Medicare fee-for-service program. The updates come on the heels of lower-than-expected model participation.  

This blog will discuss key EOM updates, application details, eligibility requirements and important deadlines. 

New cohort opportunity 

Request for applications:

CMS issued an RFA to recruit a second cohort of participants and payers for the EOM. 

Timeline: 

  • Second cohort start date: July 1, 2025 

  • Second cohort end date: June 30, 2030 

  • Initial performance period start date: July 1, 2023 

  • Model test end date for all participants: June 30, 2030 (extended from June 30, 2028) 

Notable changes to the EOM model 

  1. Model extension: The model's duration is extended by two years, to June 30, 2030. 

  1. Higher monthly payment for enhanced services: Monthly Enhanced Oncology Services payments will increase: 

  • from $70 to $110 per individual per month; and 

  • from $70 to $140 per month for dually eligible individuals. 

  1. Higher threshold for recoupment: The threshold for recoupment will rise from 98% to 100% of the benchmark amount for new episodes initiated, starting Jan. 1, 2025. 


Eligibility and participation 

Eligible participants: 

Medicare-enrolled oncology physician group practices identifiable by a unique federal taxpayer identification number. Participants must implement eight “participant redesign activities” to improve care quality. Participants are financially responsible for the total cost of care for each attributed episode (a six-month period following a Medicare recipient's qualifying cancer-related chemotherapy administration). 

Eligible payers: 

  • private payers 

  • Medicare Advantage plans 

  • State Medicaid agencies 

  • Medicaid-managed care organizations 

Application details 

Eligibility criteria: 

Detailed EOM cohort 2 eligibility criteria are available in the RFA. 

Application timeline: 

  • Application portal open date: July 1, 2024 

  • Application portal close date: Sept. 16, 2024 

Further information: 

Details on how to apply will be provided soon. 

Interested in participating? Contact DataGen today! 

These updates to the EOM reaffirm CMS' commitment to improving oncology care while managing healthcare costs effectively. The increased MEOS payments and higher recoupment thresholds reflect a significant step forward in supporting oncology practices in delivering high-quality, cost-effective care. 

For those interested in participating, mark your calendars for the application period starting July 1, 2024. CMS will have several webinar sessions with more model details this summer. DataGen’s EOM solution can help oncology practices evaluate risks and opportunities under the EOM specifications. Contact us today to get a free consultation.  

Stay tuned for more detailed information on how to apply. 

Labels:

Comments

Post a Comment

Popular posts from this blog

NCQA PCMH 2025 annual reporting: Standards and guidelines

For practices recognized under the National Committee for Quality Assurance’s (NCQA) Patient-Centered Medical Home (PCMH) model, understanding and meeting the NCQA PCMH 2025 annual reporting requirements is critical to sustaining recognition.  NCQA continues to refine its NCQA PCMH standards and guidelines , emphasizing team structure, care continuity and data integrity. Here’s what your practice needs to do to stay compliant and ensure a smooth reporting process. This blog is a continuation of our piece back in July 2024, which listed three updates to NCQA PCMH's 2025 annual reporting requirements . What is NCQA PCMH?  The NCQA Patient-Centered Medical Home (PCMH) is a model of care that emphasizes care coordination, patient engagement and continuous quality improvement. The PCMH framework is designed to improve healthcare outcomes by fostering strong patient-provider relationships and enhancing team-based care.  Since its inception, the NCQA PCMH program has evolved to...
Post a Comment
Read more

One Big Beautiful Bill Act (OBBBA): Hospital reimbursement and Medicare payments [updated]

 Updated on July 9, 2025 The One Big Beautiful Bill Act (OBBBA) — a major budget reconciliation bill passed by the U.S. House of Representatives in May — became law on July 4. While the legislation covers a wide range of national issues, several key Medicare fee-for-service (FFS) provisions could have a direct and lasting impact on hospitals and health systems.  Because OBBBA has Medicare FFS implications, DataGen analyzed the impact of these major areas. Here’s a preview of what we’re seeing so far — and what hospital leaders need to keep on their radar:  update to physician Medicare payments;  potential 4.0% additional Pay-As-You-Go (PAYGO) sequestration reduction; and  Medicare Disproportionate Share Hospital uncompensated care impact.  1. Physician payment updates   For the calendar year 2026, physician payments are slated to increase by 2.5%.   2. The potential new 6% sequester  With the new legislation, Congress may allow the Statutory...
Post a Comment
Read more